Tag:
Germany
Latest Headlines
Latest Headlines
Analyst: German court 60% likely to halt Medtronic's CoreValve sales
Expect Edwards Lifesciences' aggressive and increasingly hard-core heart valve patent battle with Medtronic to get worse in the coming weeks. An industry analyst predicts that a German court will issue an injunction preventing Medtronic from selling its CoreValve transcatheter aortic valve replacement in that country. And continued legal action is advancing in the U.S.
Pfizer denies knowledge of acquired companies' failures in East German drug trials
As Bloomberg reports, Germany's Der Spiegel has ferreted more details about drug research in Soviet-era East Germany, where pharma groups tied to some of the biggest names in the industry reportedly benefited from cheap clinical trials before the fall of the Berlin Wall.
UPDATED: German cops seize Boston Scientific stents in cutthroat patent fight
OrbusNeich Medical called the cops on Boston Scientific in Germany in a nasty escalation of their ongoing stent patent dispute.
Hated German price formula to be applied to Pradaxa, Prolia, other drugs
Drugmakers, livid with German pricing gatekeepers for turning down so many new drugs, now face a strategy that is sure to ratchet up their anger to the boiling point.
U.S. drugmakers Pfizer, J&J top reputation ranks in Germany, Italy
A new survey analysis shows that patients in Germany and Italy are much less cynical about the pharmaceutical industry than U.S. patients are.
German cost agency spurns Xalkori, Komboglyze
The well-armed German pricing gatekeepers have dismissed two more Big Pharma drugs. Pfizer's ($PFE) lung cancer treatment Xalkori and the Bristol-Myers Squibb ($BMY)/AstraZeneca ($AZN) diabetes drug Komboglyze both got an initial thumbs-down from the Institute for Quality and Efficiency in Health Care (IQWiG).
FDA says some Hameln workers don't know what they are doing
A flurry of letters promising to do better was not enough to keep the FDA from issuing a warning letter to a German maker of injectable drugs that outlines problems with its sterility procedures.
German insurers want prison for docs who take pharma kickbacks
Last year, a German court told doctors they couldn't be punished for taking money or gifts from drugmakers--and neither can the companies, even if they're paying physicians specifically to prescribe their drugs. Now, state-backed insurers are calling for a major about-face. They want doctors who take kickbacks to go to prison.
Roche invests $258M-plus into Germany Dx plant expansion
Roche Diagnostics plans to pour more than $258 million into building a new diagnostics production complex in Germany, thanks to rising demand for immunoassays of all kinds.
Is AstraZeneca answering German price cuts with German job cuts?
AstraZeneca has had its own internal troubles in yielding new drugs from its R&D pipeline, but external factors such as drug pricing impact the industry.
